In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing for a healthcare partner in Puerto Rico. By the end of November, CTS implements universal individual Zika testing on all blood donations in the US, due to an FDA requirement.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...